Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of proprietary product candidates to treat patients suffering from central nervous system diseases, particularly targeting negative symptoms of schizophrenia
Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of proprietary product candidates to treat patients suffering from central nervous system diseases, particularly targeting negative symptoms of schizophrenia.